https://orcid.org/0000-0002-7732-3591
References
- Miller R, Jackson CE, Kasarskis EJ, England JD, Forshew RN, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence based review). Report of Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009;73:1218–26.
- Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al.; The EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis. The European Federation of the Neurological Societies (EFNS) guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) – revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
- van den Berg LH, Sorenson E, Gronseth G, Macklin EA, Andrews J, Baloh RH, Airlie House ALS Clinical Trials Guidelines Group, et al. Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials. Neurology 2019;92:e1610–e23.
- Shefner JM, Cudkowicz ME, Hardiman O, Cockcroft BM, Lee JH, Malik FI, VITALITY-ALS Study Group, et al. A phase III trial of tirasemtiv as a potential treatment for amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;0:1–11.
- McCormack M, Kaminsky D. Pulmonary function laboratories: advice regarding COVID-19. ATS Dis Relat Resour 2020;1. https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/pulmonary-function-laboratories.php
- Paganoni S, Simmons Z. Telemedicine to innovate amyotrophic lateral sclerosis multidisciplinary care: the time has come. Muscle Nerve. 2019;59:3–5 (Wiley Online Library).
- Hobson EV, Baird WO, Cooper CL, Mawson S, Shaw PJ, McDermott CJ. Using technology to improve access to specialist care in amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:313–24.
- Rutkove SB, Qi K, Shelton K, Liss J, Berisha V, Shefner JM. ALS longitudinal studies with frequent data collection at home: study design and baseline data. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:61–7.
- Geronimo A, Simmons Z. Evaluation of remote pulmonary function testing in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:348–55.
- Helleman J, Kruitwagen ET, van den Berg LH, Visser-Meily JM, Beelen A. The current use of telehealth in ALS care and the barriers to and facilitators of implementation: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21:167–82.
- Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An official American thoracic Society and European respiratory Society technical statement. Am J Respir Crit Care Med. 2019;200:e70–e88.
- Brooke J. Sus: a “quick and dirty” usability. In: Usability evaluation in industry. New York, NY: Taylor & Francis; 1996:189.
- CSO. Information Society Statistics – Households 2019, Household Internet Connectivity cso.ie. 2019. Available at: https://www.cso.ie/en/releasesandpublications/ep/p-isshh/informationsocietystatistics-households2019/householdinternetconnectivity/.
- Hobson EV, Fazal S, Shaw PJ, McDermott CJ. "Anything that makes life's journey better." Exploring the use of digital technology by people living with motor neurone disease. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:378–87.
- Hobson EV, Baird WO, Partridge R, Cooper CL, Mawson S, Quinn A, et al. The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:351–61.